JP2008524183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008524183A5 JP2008524183A5 JP2007546172A JP2007546172A JP2008524183A5 JP 2008524183 A5 JP2008524183 A5 JP 2008524183A5 JP 2007546172 A JP2007546172 A JP 2007546172A JP 2007546172 A JP2007546172 A JP 2007546172A JP 2008524183 A5 JP2008524183 A5 JP 2008524183A5
- Authority
- JP
- Japan
- Prior art keywords
- peaks
- difumarate
- azd0530 difumarate
- azd0530
- scale
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0427697.8A GB0427697D0 (en) | 2004-12-17 | 2004-12-17 | Chemical process |
| GB0427697.8 | 2004-12-17 | ||
| PCT/GB2005/004807 WO2006064217A2 (en) | 2004-12-17 | 2005-12-14 | PROCESS FOR THE PREPARATION OF 4-(6-CHLORO-2, 3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-l-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE , THEIR INTERMEDIATES AND CRYSTALLINE SALTS THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008318186A Division JP2009143920A (ja) | 2004-12-17 | 2008-12-15 | 化学的方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008524183A JP2008524183A (ja) | 2008-07-10 |
| JP2008524183A5 true JP2008524183A5 (cg-RX-API-DMAC10.html) | 2009-02-19 |
| JP5161584B2 JP5161584B2 (ja) | 2013-03-13 |
Family
ID=34090249
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007546172A Expired - Lifetime JP5161584B2 (ja) | 2004-12-17 | 2005-12-14 | 化学的方法 |
| JP2008318186A Pending JP2009143920A (ja) | 2004-12-17 | 2008-12-15 | 化学的方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008318186A Pending JP2009143920A (ja) | 2004-12-17 | 2008-12-15 | 化学的方法 |
Country Status (16)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0412074D0 (en) * | 2004-05-29 | 2004-06-30 | Astrazeneca Ab | Combination product |
| WO2009068906A2 (en) * | 2007-11-26 | 2009-06-04 | Astrazeneca Ab | Combinations comprising zd4054 and a src family kinase inhibitor 172 |
| CN103275072B (zh) * | 2013-05-22 | 2016-01-20 | 苏州明锐医药科技有限公司 | 塞卡替尼的制备方法 |
| US10660957B2 (en) * | 2013-06-13 | 2020-05-26 | Yale University | Compositions and methods for treating an Aβ-modulated disease or disorder or improving cognition in a subject |
| US11241434B2 (en) | 2013-06-13 | 2022-02-08 | Yale Uninversity | Compositions and methods for improving cognition in a subject |
| WO2016130897A1 (en) | 2015-02-13 | 2016-08-18 | Yu Paul B | Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue |
| FI3930715T3 (fi) | 2019-02-27 | 2024-08-05 | Astrazeneca Ab | Sarakatinibi käytettäväksi idiopaattisen keuhkofibroosin hoidossa |
| CN116332789A (zh) * | 2023-03-10 | 2023-06-27 | 上海康鹏科技股份有限公司 | 一种4-氨基-2-氟苯甲酰胺的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73993C2 (uk) * | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| AU2001278609B2 (en) | 2000-08-21 | 2005-04-14 | Astrazeneca Ab | Quinazoline derivatives |
| ATE409185T1 (de) | 2001-04-19 | 2008-10-15 | Astrazeneca Ab | Chinazolin derivate |
| RU2350618C2 (ru) * | 2002-11-04 | 2009-03-27 | Астразенека Аб | ПРОИЗВОДНЫЕ ХИНАЗОЛИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Src ТИРОЗИНКИНАЗЫ |
| GB0226434D0 (en) | 2002-11-13 | 2002-12-18 | Astrazeneca Ab | Combination product |
| GB0307333D0 (en) | 2003-03-29 | 2003-05-07 | Astrazeneca Ab | Therapeutic agent |
| GB0309850D0 (en) * | 2003-04-30 | 2003-06-04 | Astrazeneca Ab | Quinazoline derivatives |
| GB0310401D0 (en) * | 2003-05-07 | 2003-06-11 | Astrazeneca Ab | Therapeutic agent |
-
2004
- 2004-12-17 GB GBGB0427697.8A patent/GB0427697D0/en not_active Ceased
-
2005
- 2005-12-14 KR KR1020077015972A patent/KR20070090004A/ko not_active Ceased
- 2005-12-14 WO PCT/GB2005/004807 patent/WO2006064217A2/en not_active Ceased
- 2005-12-14 CA CA002590735A patent/CA2590735C/en not_active Expired - Lifetime
- 2005-12-14 NZ NZ555468A patent/NZ555468A/en not_active IP Right Cessation
- 2005-12-14 ES ES05818127.2T patent/ES2622480T3/es not_active Expired - Lifetime
- 2005-12-14 MX MX2007007210A patent/MX2007007210A/es not_active Application Discontinuation
- 2005-12-14 CA CA002675642A patent/CA2675642A1/en not_active Abandoned
- 2005-12-14 AU AU2005315458A patent/AU2005315458B2/en not_active Expired
- 2005-12-14 US US11/793,064 patent/US8304417B2/en active Active
- 2005-12-14 KR KR1020087023973A patent/KR20080094849A/ko not_active Withdrawn
- 2005-12-14 BR BRPI0519085-1A patent/BRPI0519085A2/pt not_active IP Right Cessation
- 2005-12-14 EP EP05818127.2A patent/EP1871769B1/en not_active Expired - Lifetime
- 2005-12-14 JP JP2007546172A patent/JP5161584B2/ja not_active Expired - Lifetime
- 2005-12-14 CN CN2005800476248A patent/CN101115744B/zh not_active Expired - Lifetime
- 2005-12-14 KR KR1020087023969A patent/KR20080094846A/ko not_active Withdrawn
- 2005-12-14 KR KR1020087023972A patent/KR20080094848A/ko not_active Withdrawn
- 2005-12-14 KR KR1020087023971A patent/KR20080094847A/ko not_active Withdrawn
- 2005-12-14 KR KR1020117022793A patent/KR20110114727A/ko not_active Ceased
-
2007
- 2007-05-29 IL IL183525A patent/IL183525A0/en unknown
- 2007-05-30 NO NO20072755A patent/NO20072755L/no not_active Application Discontinuation
- 2007-05-31 ZA ZA200704532A patent/ZA200704532B/en unknown
-
2008
- 2008-12-15 JP JP2008318186A patent/JP2009143920A/ja active Pending
-
2009
- 2009-02-18 AU AU2009200622A patent/AU2009200622A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008091670A3 (en) | Organic semiconductor materials and precursors thereof | |
| RU2007110026A (ru) | ПОЛИМОРФНЫЕ И АМОРФНАЯ ФОРМЫ ФОСФАТНОЙ СОЛИ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5-ТЕТРАГИДРО-6Н-АЗЕПИНО[5.4.3-cd]ИНДОЛ-6-ОНА | |
| JP2007145875A5 (cg-RX-API-DMAC10.html) | ||
| JP2007532560A5 (cg-RX-API-DMAC10.html) | ||
| JP2010504343A5 (cg-RX-API-DMAC10.html) | ||
| JP2010509775A5 (cg-RX-API-DMAC10.html) | ||
| JP2008525416A5 (cg-RX-API-DMAC10.html) | ||
| JP2006514626A5 (cg-RX-API-DMAC10.html) | ||
| JP2006519818A5 (cg-RX-API-DMAC10.html) | ||
| CO6410293A2 (es) | Nueva formula cristalina vi de la agomelatina preparación y uso de la misma | |
| JP2008518904A5 (cg-RX-API-DMAC10.html) | ||
| WO2008126732A1 (ja) | 縮合二環式ヘテロアリール誘導体 | |
| MX2010003001A (es) | Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a. | |
| WO2006100635A3 (en) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
| WO2004101528A3 (en) | Isoquinoline derivatives and their use as gfat inhibitors | |
| JP2012502111A5 (cg-RX-API-DMAC10.html) | ||
| ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| GB0510584D0 (en) | Organic compounds | |
| WO2009080721A3 (en) | 4 -aminopyrimidine derivatives as histamine h4 receptor antagonists | |
| RS52663B2 (sr) | Nova kristalna forma tiotropijum bromida i proces njene pripreme | |
| JP2011500575A5 (cg-RX-API-DMAC10.html) | ||
| JP2010507590A5 (cg-RX-API-DMAC10.html) | ||
| ATE409179T1 (de) | Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten | |
| JP2016510767A5 (cg-RX-API-DMAC10.html) | ||
| RU2015114085A (ru) | Кристаллические формы производных дигидропиримидина |